Evolving Dynamics of the Sterilization & Disinfection Market: Trends Across Monitoring, Terminal Sterilization, Disinfection, And Barrier Solutions
- Published: Nov, 2025
- Report ID: GVR-MT-100494
- Format: PDF/Excel databook
- No. of Pages/Datapoints: 75
- Report Coverage: 2024 - 2030
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Regional scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Industry Dynamics, Trends and Scope
2.1. Industry Dynamics
2.1.1. Industry driver analysis
2.1.1.1. Growing burden of hospital acquired infection
2.1.1.2. Rising demand for high level disinfection
2.1.1.3. Growing surgical procedures
2.1.1.4. Rising focus on infection prevention and control
2.1.1.5. Rising demand for sterilization monitoring to meet regulatory compliance
2.1.2. Industry restraint analysis
2.1.2.1. Product recalls and quality issues
2.1.3. Industry opportunity analysis
2.1.3.1. Approvals of HLD products and consumables
2.1.3.2. Development of UV-C disinfection products
2.1.3.3. Rising demand for automated disinfection
2.1.3.4. Shift from manual to digital sterilization monitoring
2.1.4. Industry challenge analysis
2.1.4.1. High cost of advanced monitoring systems
2.1.4.2. Lack of standardization across regions
2.1.4.3. Maintenance and operational cost associated with medical washers and disinfectors
2.2. Industry Analysis Tools
2.2.1. Industry Analysis – Porter’s
2.2.1.1. Bargaining power of suppliers
2.2.1.2. Bargaining power of buyers
2.2.1.3. Threat of substitutes
2.2.1.4. Threat of new entrants
2.2.1.5. Competitive rivalry
2.2.2. PESTEL Analysis
2.2.2.1. Political & Legal Landscape
2.2.2.2. Economic and Social Landscape
2.2.2.3. Technological landscape
Chapter 3. Competitive Landscape
3.1. Recent Developments & Impact Analysis, By Key Market Participants
3.2. Company/Competition Categorization
3.2.1. Innovators
3.3. Vendor Landscape
3.3.1. List of key distributors and channel partners
3.3.2. Global Key company market share analysis, 2024
3.3.2.1. ASP (Fortive)
3.3.2.1.1. Company overview
3.3.2.1.2. Financial performance
3.3.2.1.3. Product benchmarking
3.3.2.1.4. Strategic initiatives
3.3.2.2. STERIS
3.3.2.2.1. Company overview
3.3.2.2.2. Financial performance
3.3.2.2.3. Product benchmarking
3.3.2.2.4. Strategic initiatives
3.3.2.3. MELAG Medizintechnik GmbH & Co. KG
3.3.2.3.1. Company overview
3.3.2.3.2. Financial performance
3.3.2.3.3. Product benchmarking
3.3.2.3.4. Strategic initiatives
3.3.2.4. Tuttnauer
3.3.2.4.1. Company overview
3.3.2.4.2. Financial performance
3.3.2.4.3. Product benchmarking
3.3.2.4.4. Strategic initiatives
3.3.2.5. Olympus
3.3.2.5.1. Company overview
3.3.2.5.2. Financial performance
3.3.2.5.3. Product benchmarking
3.3.2.5.4. Strategic initiatives
3.3.2.6. ECOLAB
3.3.2.6.1. Company overview
3.3.2.6.2. Financial performance
3.3.2.6.3. Product benchmarking
3.3.2.6.4. Strategic initiatives
3.3.2.7. Shinva Medical Instrument Co., Ltd.
3.3.2.7.1. Company overview
3.3.2.7.2. Financial performance
3.3.2.7.3. Product benchmarking
3.3.2.7.4. Strategic initiatives
3.3.2.8. Getinge
3.3.2.8.1. Company overview
3.3.2.8.2. Financial performance
3.3.2.8.3. Product benchmarking
3.3.2.8.4. Strategic initiatives
3.3.2.9. Skytron, LLC
3.3.2.9.1. Company overview
3.3.2.9.2. Financial performance
3.3.2.9.3. Product benchmarking
3.3.2.9.4. Strategic initiatives
3.3.2.10. AT-OS S.r.l.
3.3.2.10.1. Company overview
3.3.2.10.2. Financial performance
3.3.2.10.3. Product benchmarking
3.3.2.10.4. Strategic initiatives
3.3.2.11. COLTENE Group
3.3.2.11.1. Company overview
3.3.2.11.2. Financial performance
3.3.2.11.3. Product benchmarking
3.3.2.11.4. Strategic initiatives
3.3.2.12. Map Industries
3.3.2.12.1. Company overview
3.3.2.12.2. Financial performance
3.3.2.12.3. Product benchmarking
3.3.2.12.4. Strategic initiatives
3.3.2.13. Spire Integrated Solutions
3.3.2.13.1. Company overview
3.3.2.13.2. Financial performance
3.3.2.13.3. Product benchmarking
3.3.2.13.4. Strategic initiatives
3.3.2.14. Steelco S.p.A.
3.3.2.14.1. Company overview
3.3.2.14.2. Financial performance
3.3.2.14.3. Product benchmarking
3.3.2.14.4. Strategic initiatives
3.3.2.15. Belimed
3.3.2.15.1. Company overview
3.3.2.15.2. Financial performance
3.3.2.15.3. Product benchmarking
3.3.2.15.4. Strategic initiatives
3.3.2.16. Smeg
3.3.2.16.1. Company overview
3.3.2.16.2. Financial performance
3.3.2.16.3. Product benchmarking
3.3.2.16.4. Strategic initiatives
3.3.2.17. TBT Medical
3.3.2.17.1. Company overview
3.3.2.17.2. Financial performance
3.3.2.17.3. Product benchmarking
3.3.2.17.4. Strategic initiatives
3.3.2.18. DEKO MedTech Oy.
3.3.2.18.1. Company overview
3.3.2.18.2. Financial performance
3.3.2.18.3. Product benchmarking
3.3.2.18.4. Strategic initiatives
3.3.2.19. MMM Group
3.3.2.19.1. Company overview
3.3.2.19.2. Financial performance
3.3.2.19.3. Product benchmarking
3.3.2.19.4. Strategic initiatives
3.3.2.20. Nanosonics
3.3.2.20.1. Company overview
3.3.2.20.2. Financial performance
3.3.2.20.3. Product benchmarking
3.3.2.20.4. Strategic initiatives
3.3.2.21. SCHLUMBOHM Medizin-Labor-Technologie-Hamburg GmbH
3.3.2.21.1. Company overview
3.3.2.21.2. Financial performance
3.3.2.21.3. Product benchmarking
3.3.2.21.4. Strategic initiatives
3.3.2.22. KEN Hygiene Systems
3.3.2.22.1. Company overview
3.3.2.22.2. Financial performance
3.3.2.22.3. Product benchmarking
3.3.2.22.4. Strategic initiatives
3.3.2.23. Germitec
3.3.2.23.1. Company overview
3.3.2.23.2. Financial performance
3.3.2.23.3. Product benchmarking
3.3.2.23.4. Strategic initiatives
3.3.2.24. CS Medical LLC
3.3.2.24.1. Company overview
3.3.2.24.2. Financial performance
3.3.2.24.3. Product benchmarking
3.3.2.24.4. Strategic initiatives
3.3.2.25. Metrex Research, LLC
3.3.2.25.1. Company overview
3.3.2.25.2. Financial performance
3.3.2.25.3. Product benchmarking
3.3.2.25.4. Strategic initiatives
3.3.2.26. CIVCO Medical Solutions
3.3.2.26.1. Company overview
3.3.2.26.2. Financial performance
3.3.2.26.3. Product benchmarking
3.3.2.26.4. Strategic initiatives
3.3.2.27. Tristel Plc
3.3.2.27.1. Company overview
3.3.2.27.2. Financial performance
3.3.2.27.3. Product benchmarking
3.3.2.27.4. Strategic initiatives
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.